Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test

Detection Principle
total Ab vs N
Testing Method Category
Testing Method
in house: DR-ELISA (INgezim COVID 19 DR), DR-LFA (INgezim COVID 19 CROM)
Testing Method - Additional Info
Two serological tools based on a double recognition assay: enzyme-linked immunosorbent assay (DR-ELISA) and lateral flow assay (DR-LFA)
Reported Performance
sensitivity: 91.2% (DR-LFA), 100% (DR-ELISA); specificity: 100% (DR-LFA), 98.2% (DR-ELISA)
Sample Size
1065 samples

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements